- Japan’s Astellas to buy US biotech group Iveric Bio for $5.9bn Financial Times
- Astellas Enters into Definitive Agreement to Acquire Iveric Bio PR Newswire
- Astellas Pharma buys Iveric Bio for $5.9 billion Reuters
- Iveric Bio (NASDAQ:ISEE) Sold for $5.9B TipRanks
- Japan’s Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil. Kyodo News Plus
- View Full Coverage on Google News
Noutati
-
Cata prostie incape intr-un papuc? | 11 ian. 2009
-
Aproximativ 18 milioane de cetăţeni cu drept de vot sunt aşteptaţi la urne pe 30 noiembrie | 28 nov. 2008
-
County investigates first locally acquired dengue case in Escondido – FOX 5 San Diego | 07 oct. 2024
-
‘Ridiculous and just plain false’: FEMA administrator knocks Trump’s Hurricane Helene recovery claims – USA TODAY | 07 oct. 2024
-
Taylor Swift attending Travis Kelce’s Chiefs game vs. Saints after missing last two – New York Post | 07 oct. 2024
-
Stock market’s soft-landing rally faces crucial CPI inflation test. – MarketWatch | 07 oct. 2024
-
Tony Fadell-backed Plumerai brings on-device AI to home security cameras – TechCrunch | 07 oct. 2024
-
Your iPhone 16 may get its first Apple Intelligence features later this month – The Verge | 07 oct. 2024
